Acumen Pharmaceuticals Capital Expenditures (CapEx) Growth & History (ABOS)

Acumen Pharmaceuticals's capital expenditures (capex) was $88,000 for fiscal 2025.

View full Acumen Pharmaceuticals company overview

Acumen Pharmaceuticals annual capital expenditures (capex) history

Acumen Pharmaceuticals annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$88,000$72,000+450.00%
20242024-12-31$16,000−$5,000−23.81%
20232023-12-31$21,000−$140,000−86.96%
20222022-12-31$161,000$121,000+302.50%
20212021-12-31$40,000

Acumen Pharmaceuticals capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's capital expenditures (capex) increased from $40,000 to $88,000, a change of $48,000. The latest reported quarter, Q2 2026, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Acumen Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about ABOS yet. Start the conversation.

Write the first post